Literature DB >> 6375579

Adjuvant therapy of pemphigus.

J C Bystryn.   

Abstract

The effectiveness of adjuvant therapy of pemphigus was evaluated by comparing the results of studies of pemphigus treated with corticosteroids and adjuvant as opposed to corticosteroids only. There has been a steady and striking improvement in the prognosis of pemphigus during the past three decades. However, factors other than the use of adjuvant therapy appear to be responsible, since the survival and incidence of remissions in patients treated with adjuvants was only slightly better than that of patients treated with corticosteroids alone. The variable course of pemphigus and the lack of stratification makes it difficult to judge whether these slight differences have any relevance. A suggested protocol to treat pemphigus is presented.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6375579

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  12 in total

1.  Vesiculo-bullous disorders in adulthood.

Authors:  R M McKay
Journal:  Can Fam Physician       Date:  1987-12       Impact factor: 3.275

Review 2.  What's new in blistering disorders?

Authors:  Paru Chaudhari; M Peter Marinkovich
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

Review 3.  Medicine in the elderly.

Authors:  P Diggory; A Homer; J Liddle; C F Pratt; S Samadian; R Tozer; C Weinstein
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

Review 4.  Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics.

Authors:  A Anstey
Journal:  J R Soc Med       Date:  1995-03       Impact factor: 5.344

Review 5.  Pemphigus vulgaris: an evidence-based treatment update.

Authors:  Cathy Y Zhao; Dedee F Murrell
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

Review 6.  Novel therapies for pemphigus vulgaris: an overview.

Authors:  Oliver A Perez; Timothy Patton
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

7.  High levels of interleukin-1 in patients with endemic pemphigus foliaceus.

Authors:  Denise Bertulucci Rocha-Rodrigues; Giovana Paschoini; Sanivia Aparecida Lima Pereira; Marlene Antonia dos Reis; Vicente de Paula Antunes Teixeira; Virmondes Rodrigues Júnior
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

8.  Therapy of autoimmune bullous diseases.

Authors:  Diya F Mutasim
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

Review 9.  Beneficial effects and safety of corticosteroids combined with traditional chinese medicine for pemphigus: a systematic review.

Authors:  Tingting Zhou; Peiru Zhou; Hong Hua; Xiaosong Liu
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-22       Impact factor: 2.629

10.  Correlation between polymorphisms of the NR3C1 gene and glucocorticoid effectiveness in patients with pemphigus vulgaris.

Authors:  Si-Yue Fang; Chun-Lei Li; Xiao-Song Liu; Feng Chen; Hong Hua
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.